Species-Crossreactive scFv Against the Tumor Stroma Marker "Fibroblast Activation Protein" Selected by Phage Display from an Immunized FAP-/- Knock-Out Mouse

Molecular Medicine

Volumn 7, Issue 7, 2001, Pages 461-469

  Brocks, Bodo ^a,d   Garin Chesa, Pilar ^b   Behrle, Eva ^a   Park, John E ^b   Rettig, Wolfgang J ^b   Pfizenmaier, Klaus ^a   Moosmayer, Dieter ^a,c  

^a UNIVERSITY OF STUTTGART   (Germany)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^c BAYER PHARMA AG   (Germany)

^d MORPHOSYS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAP PROTEIN, HUMAN; FAP PROTEIN, MOUSE; GROWTH PROMOTOR; HYBRID PROTEIN; MEMBRANE PROTEIN; PEPTIDE LIBRARY; PRIMER DNA; SERINE PROTEINASE; TUMOR ANTIGEN; TUMOR MARKER;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CROSS REACTION; EXPERIMENTAL NEOPLASM; GENETICS; HUMAN; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NEOPLASM; NUCLEOTIDE SEQUENCE; NUDE MOUSE; POLYMERASE CHAIN REACTION; SPECIES DIFFERENCE; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; CROSS REACTIONS; DNA PRIMERS; GROWTH SUBSTANCES; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; SERINE ENDOPEPTIDASES; SPECIES SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035407983     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401851     Document Type: Article

References (33)

1. Garin-Chesa P, Old LJ, Rettig WJ. (1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibodytarget in human epithelial cancers. Proc. Natl. Acad. Sci. USA 87: 7235-7239.
2. Welt S, Divgi CR, Scott AM, et al. (1994) Antibody targeting in metastasing colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive stromal fibroblasts. J. Clin. Oncol 12: 1193-1203.
3. Hanahan D, Folkman J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
4. Barinaga M. (1997) Designing therapies that target tumor blood vessels. Science 275: 482-484.
5. Zetter BR. (1997) On target with tumor blood vessel markers. Nature Biotechnol. 15: 1243-1244.
6. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. (1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol. Chem. 274: 36505-36512.
7. Rettig WJ, Garin-Chesa B Beresford HR, Oettgen HF, Melamed MR, Old LJ. (1988) Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl. Acad. Sci. USA 85: 3110-3114.
8. Rettig WJ, Garin-Chesa P, Healey J, et al. (1993) Regulation and heterodimeric structure of the firoblast activation protein in normal and transformed cells of mesenchymal and neurocctodermal origin. Cancer Res. 53: 3327-3335.
9. Scanlan MJ, Raj BK, Calvo B, et al. (1994) Molecular cloning of fibroblast activation protein a, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl. Acad. Sci. USA 91: 5657-5661.
10. Niedermeyer J, Scanlan MJ, Garin-Chesa P, et al. (1997) Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int. J. Cancer 71: 383-389.
11. Hayden MS, Gilliland LK, Ledbetter JA. (1997) Antibody engineering. Curr. Opin. Immunol. 9: 201-212.
12. Carter P, Merchant MA. (1997) Engineering antibodies for imaging and therapy. Curr. Opin. Biotechnol. 8: 449-454.
13. Niedermeyer J, Kriz M, Hilberg F, et al. (2000) Targeted distribution of mouse fibroblast activation protein. Mol. Cell. Biol 20: 1089-1094.
14. Zhou H, Fisher RJ, Papas TS. (1994) Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res. 22: 888-889.
15. Datmajumdar AK, Jacobson DP, Hood LE, Osman GE. (1996) Rapid cloning of any rearranged mouse immunoglobulin variable genes. Immunogenetics 43: 141-151.
16. Welschof M, Little M, Dörsam H. (1997) Production of a human antibody library in the phage display vector pSEX81. In: Walker JM, ed: Molecular Biology Based Methods in Clinical Diagnosis. In the series Methods in Molecular Medicine. Totowa, NJ: Humana Press.
17. Welschof M, Terness P, Kyprijanov S, et al. (1997) The antigen binding domain of a human IgG anti F(ab')2 autoantibody. Proc. Natl. Acad. Sci. U.S.A. 94: 1902-1907.
18. Schmiedl A, Breitling F, Winter CH, Queitsch I, Dübel S. (2000) Effects of unpaired cysteins on yield, solubility and activity of different recombinant antibody constructs expressed in E. coli. J. Immunol. Meth. 242: 101-114.
19. Rippmann FJ, Klein M, Hoischen, et al. (1998) Procaryotic expression of single-chain variable-fragment (scFv) antibodies: secretion in L-form cells of Proteus mirabilis leads to active product and overcomes the limitations of periplamic expression in Escherichia coli. Appl. Environ. Microbiol. 64: 4862-4869.
20. Friguet B, Chaffotte AF, Djyvadi-Ohaniance L, Goldberg ME. (1985) Meaurement of true affinity constant in solution of antigen antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Meth. 77: 305-319.
21. Hu S, Shively L, Raubitschek A, et al. (1996) Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts. Cancer Res. 56: 3055-3061.
22. Moosmayer D, Dübel S, Brocks B, et al. (1995) A single-chain TNF receptor antagonist is an effective inhibitor of TNF mediated cytotoxicity. Therap. Immunol. 2: 31-40.
23. Dübel S, Breitling F, Fuchs P, et al. (1994) Isolation of IgG antibody Fv DNA from various mouse and rat hybridoma cell lines using the polymerase chain reaction with a simple set of primers. J. Immunol Meth. 175: 89-95.
24. Tesar M, Beckmann C, Róttgen T, Haase B, Faude U, Timmis KN. (1995) Monoclonal antibody against filamentous phage: An immunological tool to study pIII-fusion protein expression in phage display systems. Immunotechnology 1: 53-64.
25. Mersmann M, Schmidt A, Tesar M, et al. (1998) High efficient monitoring of scFv selected from phage display repertoires using detection of scFv-pIII fusion proteins in a microtiter scale assay. J. Immunol. Meth. 220: 51-58.
26. Kabat EA, Wu TT, Perry HM, Gottesmann KS, Foeller C. (1991) Sequences of Proteins of Immunological Interest, 5th ed. Bethesda, MD: US Department of Health and Human Services.
27. Mersmann M, Schmidt A, Wüest T, et al. (2001) Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas. Int. J. Cancer 92:240-248.
28. Sakano H, Maki R, Kuroswa Y, Roeder W, Tonegawa S. (1980) Two types of somatic recombination are necessary fot the generation of complete immunoglobulin heavy-chain genes. Nature 286: 676-683.
29. Rettig WJ, Su SL, Fortunato SR, et al. (1994) Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int. J. Cancer 58: 385-392.
30. Williamson RA, Peretz D, Smorodinsky N, et al. (1996) Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc. Natl. Acad. Sci. U.S.A. 93: 7279-7282.
31. Brinkmann U. (2000) Recombinant antibody fragments and immunotoxin fusions for cancer therapy. In Vivo 14: 21-27.
32. Kipriyanov SM, Moldenbauer G, Little M. (1996) High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol Meth. 200: 69-77.
33. Ames RS, Tornetta MA, Me Millan FJ, et al. (1995) Neutralizing murine monoclonal antibodies against human IL 5 isolated from hybridomas and filamentous Fab display library. J. Immunol. 154: 6355-6364.